key: cord-0932133-vbp4wrwx
authors: Lai, Chih-Cheng; Chen, Chin-Ming; Liao, Kuang-Ming; Chao, Chien-Ming; Chan, Khee-Siang; Yu, Weng-Liang
title: A Mysterious Surge of Aspergillosis among Non-SARS-CoV-2 Patients during COVID-19 Pandemic
date: 2020-12-01
journal: J Microbiol Immunol Infect
DOI: 10.1016/j.jmii.2020.11.002
sha: 851ed005b6ac68e423adb1c09033abb145776b7b
doc_id: 932133
cord_uid: vbp4wrwx

nan

Taiwan. [1] [2] [3] [4] Additionally, co-infection of aspergillosis with COVID-19 has been reported. 5 Would the pulmonary aspergillosis increase or decrease while physicians fighting COVID-19 pandemic?

We retrieved computerized data of Aspergillus galactomannan testing from blood and respiratory specimens (endobronchial aspirates or bronchoalveolar lavage fluid).

The computerized data included results of galactomannan testing, physician-in-charge, and case-site allocation. Aspergillosis was defined by positive galactomannan testing at a cutoff index of 0.5. We use the Taiwan Centers for Disease Control and Prevention national website (https://nidss.cdc.gov.tw/en/) to obtain the laboratory-confirmed COVID-19 cases.

The indigenous COVID-19 outbreak had occurred between calendar week 4 and week 15, with a peak between 11th-13rd weeks in Taiwan. There were only 3 imported cases were admitted to one of the current study institutes. Therefore, our study mainly observed non-COVID-19 patients who acquired aspergillosis during the In Taiwan, SARS-CoV-2 was tested for risk persons who exposed to infected cases and for targeted indications of anyone with pneumonia of unknown etiology.

Clinicians, therefore, would try every effort to recognize "unknown etiology" by excluding the potential pathogens of pneumonia. In addition to routine microbiological investigations, Aspergillus galactomannan assay could be applied. In 

Collateral benefit of COVID-19 control measures on influenza activity

Severe complicated influenza declined during the prevention of COVID-19 in Taiwan

Collateral benefits on other respiratory infections during fighting COVID-19

Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?

COVID-19 associated with pulmonary aspergillosis: A literature review

We thank Mei-Yu Su at Department of Intensive Care Medicine, Chi Mei Medical Center, for data collection.

All authors have no potential conflicts.